The Safety and Effectiveness of Nevirapine and Zidovudine, Given Separately and Together, in HIV-1 Infected Patients Who Have No Symptoms of the Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Nevirapine

DRUG

Zidovudine

Trial Locations (18)

10001

Community Research Initiative on AIDS, New York

19107

Philadelphia FIGHT, Philadelphia

19801

Wilmington Hosp, Wilmington

22203

Infectious Disease Physicians Inc, Annandale

23219

Richmond AIDS Consortium, Richmond

29204

Dr Alfred F Burnside Jr, Columbia

32751

Goodgame Med Group, Maitland

33146

Community Research Initiative of South Florida, Coral Gables

43699

Med College of Ohio, Toledo

67214

Univ of Kansas School of Medicine, Wichita

74114

Associates Med and Mental Health, Tulsa

75219

Nelson-Tebedo Community Clinic, Dallas

77006

Houston Clinical Research Network, Houston

84132

Univ of Utah School of Medicine, Salt Lake City

92103

UCSD Treatment Ctr, San Diego

94109

Saint Francis Mem Hosp, San Francisco

405360084

Chandler Med Ctr, Lexington

641082792

Kansas City AIDS Research Consortium, Kansas City

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00002324 - The Safety and Effectiveness of Nevirapine and Zidovudine, Given Separately and Together, in HIV-1 Infected Patients Who Have No Symptoms of the Disease | Biotech Hunter | Biotech Hunter